Kardigan Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Kardigan Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
KARD
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002123613

Board of directors

Follow this board

Chief executives

Anastasios Gianakakos · President & CEO
Since June 2026

Board connections

9 of this board's directors also sit on 32 other boards.

Network of Kardigan Inc.'s board connections Neumora Therapeutics Inc. Neumora Therapeutics I... Rhythm Pharmaceuticals Inc. Rhythm Pharmaceuticals... 10x Genomics Inc. 10x Genomics Inc. 908 Devices Inc. 908 Devices Inc. Adagio Medical Holdings Inc Adagio Medical Holding... Beam Therapeutics Inc. Beam Therapeutics Inc. BioMarin Pharmaceutical Inc. BioMarin Pharmaceutica... Boundless Bio Inc. Boundless Bio Inc. Century Therapeutics Inc. Century Therapeutics I... Freenome Inc. Freenome Inc. Gossamer Bio Inc. Gossamer Bio Inc. Immatics N.V. Immatics N.V. Kiniksa Pharmaceuticals International plc Kiniksa Pharmaceutical... Latigo Biotherapeutics Inc. Latigo Biotherapeutics... LeonaBio Inc. LeonaBio Inc. Lyell Immunopharma Inc. Lyell Immunopharma Inc... David P. Meeker David P. Meeker Joseph Edelman Joseph Edelman Keith Crandell Keith Crandell Kimberly J. Popovits Kimberly J. Popovits Kristina Burow Kristina Burow Paul L. Berns Paul L. Berns Robert Nelsen Robert Nelsen Timothy P. Walbert Timothy P. Walbert Kardigan Inc.
Shared director Other board Same sector +16 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$90,000,000
3 purchases by 3 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 22, 2026 HRTG PV, L.P. 10% owner Open-market purchase +3,125,000 $16.00 $50,000,000
Jun 22, 2026 Paul L. Berns Director, 10% owner Open-market purchase +1,250,000 $16.00 $20,000,000
Jun 22, 2026 Robert Nelsen Director, 10% owner Open-market purchase +1,250,000 $16.00 $20,000,000
Jun 17, 2026 Johnson Keith Bryon 10% owner Derivative conversion +2,050,166 — —
Jun 17, 2026 ARCH Venture Partners XIII, LLC Director, 10% owner Derivative conversion +13,792,035 — —
Jun 17, 2026 Andy Pasternak Officer (Chief Strategy Officer) Grant or award +79,640 — —
Jun 17, 2026 David P. Meeker Director Grant or award +20,706 — —
Jun 17, 2026 Paul L. Berns Director, 10% owner Derivative conversion +13,792,035 — —
Jun 17, 2026 Moriarty John B Officer (Chief Legal Officer) Grant or award +47,784 — —
Jun 17, 2026 Jahn Brianne Officer (Chief Financial Officer) Grant or award +79,640 — —
Jun 17, 2026 Kimberly J. Popovits Director Grant or award +20,706 — —
Jun 17, 2026 Timothy P. Walbert Director Grant or award +20,706 — —
Jun 17, 2026 Anastasios Gianakakos Director, Officer (President & CEO) Derivative conversion +28,702 — —
Jun 17, 2026 Douglas E. Giordano Director Grant or award +20,706 — —
Jun 17, 2026 Edelberg Jay Officer (Chief Medical Officer) Derivative conversion +97,587 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.